Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Ginseng Labeling Enforcement Stressed In House Ag Approps Bill

This article was originally published in The Tan Sheet

Executive Summary

FDA needs to take a more active approach to ensure that herbs that do not fall under the Panax genus are not labeled as "ginseng," the House Appropriations Committee states in its report on the FY 2003 Agriculture Appropriations bill

You may also be interested in...



FDA Radiation Label Change Positive, But “Material Change” Issue Troubling

FDA's proposal to revise labeling regulations for irradiated dietary supplements and food products could ease label requirements, but how the regulation would measure "material change" from radiation leaves the possibility for a bigger burden, trade groups say

FDA Radiation Label Change Positive, But “Material Change” Issue Troubling

FDA's proposal to revise labeling regulations for irradiated dietary supplements and food products could ease label requirements, but how the regulation would measure "material change" from radiation leaves the possibility for a bigger burden, trade groups say

FDA Radiation Label Change Positive, But “Material Change” Issue Troubling

FDA's proposal to revise labeling regulations for irradiated dietary supplements and food products could ease label requirements, but how the regulation would measure "material change" from radiation leaves the possibility for a bigger burden, trade groups say

Related Content

Topics

UsernamePublicRestriction

Register

PS094268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel